NCT05640544

Brief Summary

The purpose of this study is to elucidate the occurrence of Gamma entrainment and optimize the acousto-optic stimulation parameters to induce it in patients with disorders of consciousness (DOC), to explore the prognostic value of gamma entrainment in patients with DOC, and to clarify the effect of gamma entrainment on the recovery of awareness in DOC patients. This study is divided into three parts. The first and third parts are prospective cohort studies, the second part is a randomized cross control study. We recruit DOC patients, including vegetative state/unresponsive wakefulness syndrome (VS/UWS) or minimally conscious state (MCS). The patients receive sound and light stimulation in the Gamma band, and the changes of EEG are observed simultaneously to explore the occurrence of Gamma entrainment. Meanwhile, the changes of clinical behavior of patients before and after stimulation are evaluated.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2021

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

October 31, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 7, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

December 7, 2022

Status Verified

December 1, 2021

Enrollment Period

2.3 years

First QC Date

October 31, 2022

Last Update Submit

December 6, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • The changes of EEG during stimulation procedure

    The changes of Gamma oscillation, the temporal and spatial distribution of Gamma band power and the changes of Gamma band brain network are analyzed before and after stimulation.

    Synchronous recording during stimulation procedure

Secondary Outcomes (3)

  • CRS-R scale

    at two weeks, 3 months, 6 months and 1 year after the onset.

  • Glasgow Outcome Scale - Extended (GOS-E)

    at two weeks, 3 months, 6 months and 1 year after the onset.

  • Modified Rankin Scale (mRS)

    at two weeks, 3 months, 6 months and 1 year after the onset.

Study Arms (1)

Sound and light stimulation in Gamma band

EXPERIMENTAL
Other: Sound and light stimulation in Gamma band

Interventions

We expect to screen out the efficacy of Gamma band in the prognosis and treatment of disorders of consciousness by various frequencies of stimulation. Optical stimulation: A computer program is used to control the flashing frequency of LED lights for stimulation. The serial port can convert the parallel data characters of the computer CPU into a continuous serial data stream. According to the frequency designed by experiment (10Hz, 20hz, 40hz, 80hz), we modulate the flicker frequency of LED lamp. LED lamp uses T8 lamp, diameter 25.4 mm, length 620 mm, and power 20W. Acoustic stimulation: We use Adobe Audition CC 2022 to modulate the tones. The tones modulated to 10Hz, 20Hz, 40Hz and 80Hz are play by noise-canceling headphones to the patients.

Sound and light stimulation in Gamma band

Eligibility Criteria

Age16 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age 16-80 years; Clinical diagnosis of VS/UWS or MCS according to the CRS-R score within one week after admission; Time post-onset \> 28 days.

You may not qualify if:

  • Previous history of acquired brain injury or psychiatric or neurodegenerative diseases; Clinical diagnosis of epilepsy; Visual or auditory pathway damage; Life threatening comorbidity, coexisting neoplasms, severe organ dysfunction, or unstable clinical condition (e.g., hemodynamic instability or severe respiratory failure); Incomplete clinical data.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Neurology, Xijing Hospital, Air Force Medical University

Xi'an, China

RECRUITING

MeSH Terms

Conditions

Consciousness Disorders

Interventions

Sound

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Radiation, NonionizingRadiationPhysical Phenomena

Central Study Contacts

Xiaogang Kang, MD,PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 31, 2022

First Posted

December 7, 2022

Study Start

March 1, 2021

Primary Completion

June 30, 2023

Study Completion

December 31, 2025

Last Updated

December 7, 2022

Record last verified: 2021-12

Locations